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Cognitive reserve associated with
FDG-PET in preclinical Alzheimer disease
ABSTRACT
Objective: To examine the effect of education (a surrogatemeasure of cognitive reserve) on FDG-PET
brain metabolism in elderly cognitively healthy (HC) subjects with preclinical Alzheimer disease (AD).
Methods: Fifty-twoHC subjects (mean age75 years) with FDG-PET andCSFmeasurement of Ab1-42
were included from the prospective Alzheimer’s Disease Neuroimaging Initiative biomarker study. HC
subjects received a research classification of preclinical AD if CSF Ab1-42 was,192 pg/mL (Ab1-42
[1]) vs HC with normal Ab (Ab1-42 [2]). In regression analyses, we tested the interaction effect
between education and CSF Ab1-42 status (Ab1-42 [1] vs Ab1-42 [2]) on FDG-PET metabolism in
regions of interest (ROIs) (posterior cingulate, angular gyrus, inferior/middle temporal gyrus) and the
whole brain (voxel-based).
Results: An interaction between education and CSF Ab1-42 status was observed for FDG-PET in
the posterior cingulate (p, 0.001) and angular gyrus ROIs (p5 0.03), but was not significant for
the inferior/middle temporal gyrus ROI (p 5 0.06), controlled for age, sex, and global cognitive
ability (Alzheimer’s Disease Assessment Scale–cognitive subscale). The interaction effect was
such that higher education was associated with lower FDG-PET in the Ab1-42 (1) group, but with
higher FDG-PET in the Ab1-42 (2) group. Voxel-based analysis showed that this interaction effect
was primarily restricted to temporo-parietal and ventral prefrontal brain areas.
Conclusions: Higher education was associated with lower FDG-PET in preclinical AD (Ab1-42 [1]),
suggesting that cognitive reserve had a compensatory function to sustain cognitive ability in
presence of early AD pathology that alters FDG-PETmetabolism. Neurology 2013;80:1194–1201
GLOSSARY
AD 5 Alzheimer disease; ADAS 5 Alzheimer’s Disease Assessment Scale; ADAS-cog 5 ADAS–cognitive subscale; ADNI 5
Alzheimer’s Disease Neuroimaging Initiative; HC 5 cognitively healthy; MCI 5 mild cognitive impairment; PiB 5 Pittsburgh
compound B; ROI 5 region of interest.
According to the cognitive reserve hypothesis, persons with higher cognitive reserve can sustain
cognitive function in presence of more brain pathology than subjects with lower cognitive
reserve.1,2 In Alzheimer disease (AD) dementia, patients with higher education exhibited a
stronger brain pathology including reduced temporo-parietal FDG-PET or SPECT measures
when compared to patients with AD dementia with low education at similar levels of dementia
severity.3 Such an association between higher cognitive reserve and lower FDG-PETmetabolism
in patients with AD dementia has been replicated when cognitive reserve was assessed with
alternative measures including IQ,4 schooling,5 occupation, and lifetime activities,4,6 supporting
the robustness of the findings in AD dementia. These results are consistent with the cognitive
reserve hypothesis in AD, i.e., at a given level of cognitive performance, subjects with higher
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education can tolerate stronger reduction of
FDG-PET metabolism compared to subjects
with lower cognitive reserve (education).
The major aim of the current study was to
test the association between cognitive reserve
(education) and temporo-parietal FDG-PET
metabolism in individuals who meet research
criteria for preclinical AD7 (i.e., cognitively
healthy [HC] with abnormal CSF biomarker
levels of Ab). We hypothesized that, control-
ling for cognitive performance, higher cognitive
reserve would be associated with lower tem-
poro-parietal FDG-PET. The rationale for
focusing on Ab as the measure of primary
AD pathology was based on previous results
from a brain autopsy study showing that edu-
cation reduced the impact of Ab pathology but
not tau pathology on cognitive performance.8
METHODS Subjects. The study included 52 HC subjects re-
cruited within the North American multicenter Alzheimer’s Disease
Neuroimaging Initiative (ADNI; for database, see www.loni.ucla.
edu/ADNI). In ADNI (phase I, 2005–2010), a total of 229 HC
subjects were recruited. The study design, however, was such that
only a subset of subjects received both a FDG-PET scan and CSF
Ab1-42 measurement at baseline, and thus the current sample
included a total of 52 subjects (one subject was excluded due to
misregistration of FDG-PET scans; figure e-1 on the Neurology®
Web site at www.neurology.org). For the classification as HC, sub-
jects had to show normal performance on the Logical Memory II
Subscale adjusted for education as follows: 0–7 years: $3, 8–15
years:$5, 16 or more years:$9, and absence of significant impair-
ment on cognitive function or activities of daily living.9
HC subjects were dichotomized based on pre-established cut-
off points derived from postmortem-verified AD dementia pa-
tients vs living HC subjects.10 Normal CSF Ab1-42 levels were
considered $192 pg/mL (Ab1-42 [2]) and abnormal levels were
,192 pg/mL (Ab1-42 [1]).10 In the ADNI study, it was previ-
ously reported that HC subjects showed a bimodal distribution of
CSF Ab1-42 levels, where a cutoff value of 192 pg/mL separated
well subjects into high and low Ab1-42 groups,11,12 thus providing
a good basis for distinguishing groups with normal and abnormal
CSF Ab1-42 levels. HC subjects with CSF Ab1-42 (1) were clas-
sified as preclinical AD according to recently proposed research
criteria for preclinical AD.7
General inclusion criteria were an age between 55 and 90 years,
a modified Hachinski score #4, education of at least 6 grade level,
and stable treatment of at least 4 weeks in case of treatment with
permitted medication (for full list see http://www.adni-info.org,
Procedures Manual). Subjects who did not have MRI, FDG-
PET, and CSF assessment were excluded by list-wise exclusion.
Standard protocol approvals, registrations, and patient
consents. The study was approved after ethical review and writ-
ten patient consent was obtained by the ADNI investigators.
Neuropsychological assessment. Episodic memory perfor-
mance was quantified by a composite episodic memory score
based on different neuropsychological tests including the Rey
Auditory Verbal Learning Test (word list learning trials, recall,
and recognition), Alzheimer’s Disease Assessment Scale (ADAS,
word list learning, recall, and recognition), Mini-Mental State
Examination (word recall), and Logical Memory I and II, as pre-
viously described,13 and were downloaded from the ADNI Web
page (http://adni.loni.ucla.edu/). The executive function test
score included a range of different test scores as described in
reference 13a. Briefly, scores were subjected in an iterative
process to a confirmatory factor analysis and a flexible
recoding of test scores to preserve variability at the
extremes of the distribution.13
CSF measurement. All CSF samples collected at the different
centers were shipped on dry ice to the Penn ADNI Biomarker
Core Laboratory at the University of Pennsylvania, Philadelphia,
for storage at280°C until further analysis at the laboratory. More
details on data collection of the CSF samples can be found at
http://www.adni-info.org, under “ADNI study procedures.” The
CSF concentrations of Ab1-42 were measured in the baseline CSF
samples using the multiplex xMAP Luminex platform (Lumnix
Corp., Austin, TX) at the Penn ADNI Biomarker Core Labora-
tory. For detailed description, see reference 10.
FDG-PET acquisition and region of interest measurement.
FDG scans were collected as 6 3 5–minute frames beginning
30 minutes after injection of approximately 5 mCi of tracer.
Attenuation correction was performed either via transmission
scan or CT. Images were downloaded from the ADNI data bank
(http://adni.loni.ucla.edu/) after they had been preprocessed to pro-
vide standard orientation, voxel size, and resolution.
FDG-PET regions of interest (ROIs) were constructed based
on a meta-analysis of the location of FDG-PET changes in the brain
that are typically affected in AD, as described previously.14,15 For the
voxel-based analysis of FDG uptake, spatial normalization parame-
ters were estimated via high-dimensional diffeomorphic mapping
using the tool DARTEL of the software program SPM8 (Wellcome
Trust Centre for Neuroimaging, University College London, Lon-
don, UK). The FDG-PET scans were coregistered to the T1 MRI
scans and the spatial normalization parameters were applied to the
coregistered FDG-PET scans. Subsequently, the signal intensity of
FDG-PET scans was normalized to a reference region including the
pons (dividing each voxel value by the average FDG-PET within
the pons) and spatially smoothed with an 8-mm full-width-at-half-
maximum Gaussian kernel.
Statistics. For the FDG-PET ROI-based analysis, linear regression
was used to test the interaction effect between education (years) 3
CSF Ab1-42 status on FDG-PET. Global cognitive ability was con-
trolled for through ADAS–cognitive subscale (ADAS-cog) scores in
all regression models. We repeated the regression analysis controlling
either for the composite score of episodic memory or executive
function. Prior to building regressionmodels, the influence of poten-
tial confounding variables, i.e., age, sex, and APOE genotype (APOE
e4 carriers vs APOE e4 noncarriers), was tested in simple regression
models to predict FDG-PET in each ROI. Only age was signifi-
cantly associated with FDG-PET in at least one of the ROIs and age
was therefore included in all regression models as a covariate.
The interaction term education3 CSF Ab1-42 status was con-
sidered significant if the model fit was significantly improved by
including the interaction term compared to the alternative model
where CSF Ab1-42 status and education were only additive terms.
The difference between the fit of both regression models was tested
in likelihood ratio tests. In the main regression analysis, we con-
trolled for cognition as measured by ADAS-cog, but we computed
additional regression analyses to control for more specific cognitive
differences including composite scores of episodic memory or exec-
utive function. Residuals of the regression models were tested for
deviance from the normal distribution, using the Shapiro-Wilk test.
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For inferior/middle temporal lobe ROI of FDG-PET (when con-
trolling for ADAS-cog), and, in addition, for the angular gyrus
(when controlling for episodic memory score), the residuals of
the regression analysis were not normally distributed (p , 0.05).
Therefore, the variables were log-transformed and the regression
analysis repeated. The distribution of the residuals was no longer
different from a normal distribution after log transformation. If an
interaction term was significant, the robustness of the statistical
significance with regard to the potential influence of outliers was
tested by robust regression, using iterated reweighted least squares,
which reduces the weights for data points with large residuals.16 All
statistical ROI analyses were done with the statistical software R
2.12 (freely available at http://www.r-project.org/).
In order to explore the spatial distribution of the interaction effect
between education and Ab status in brain areas other than the
temporo-parietal ROIs, voxel-wise multiple regressionmodels includ-
ing age, ADAS-cog, education, CSF Ab1-42 status, and education3
CSF Ab1-42 status as predictors were computed. The resulting t sta-
tistic maps of the interaction effect were thresholded at the voxel level
at p 5 0.01 and false discovery rate corrected at the cluster level at
p5 0.05. In addition, we computed the effect size d derived from the
t statistic of the interaction term17 in order to render the distribution
of descriptive effect sizes of the interaction term independent of a
significance threshold and sample size–related statistical power. All
voxel-wise regression analyses were computed in SPM 8.
RESULTS Descriptive statistics of the mean and SD
on demographic, clinical, and APOE genotype data
for both HC Ab1-42 (2) and HC Ab1-42 (1) groups
and the total sample are displayed table 1. Mean
FDG-PET ROI values are displayed for both HC
groups in table 2. The association between education
and cognitive variables in the whole sample is descri-
bed in appendix e-1.
ROI-based analysis of interaction effect of education 3
CSF Ab1-42 status on FDG-PET. The results of the
regression analysis are presented in table 3. For the
posterior cingulum FDG-PET ROI, regression analy-
sis showed significant main effects for age (p , 0.01),
education (p , 0.01), and CSF Ab1-42 status (p ,
0.01). The hypothesized interaction effect of education
3 CSF Ab1-42 status was significant (p 5 0.001,
figure 1A). When including the interaction term, the
overall model fit was improved (x2 5 11.7, p ,
0.001). For the angular gyrus FDG-PET ROI, the
main effect of age was significant (p 5 0.01), but
not the main effect of education (p 5 0.16). The
hypothesized interaction effect between education
and CSF Ab status was significant (p 5 0.03, figure
1B) and improved the overall model fit (x25 4.9, p5
0.03). Repeating the analysis with robust regression to
control for potential outliers showed similar regression
coefficients of the interaction terms for both the pos-
terior cingulum FDG-PET ROI (B 5 20.03, SE 5
0.01, p 5 ,0.01) and the angular gyrus FDG-PET
ROI (20.03, SE 5 0.01, p 5 0.05). For the inferior/
middle temporal gyri FDG-PET ROI, the interaction
effect (B 5 20.01, SE 5 0.01, p 5 0.06) and the
change in the overall model fit (x2 5 3.6, p 5 0.06)
failed to reach the signficance threshold. As shown in
figure 1, the interactions between education and CSF
Ab status (controlled for ADAS-cog) for the posterior
cingulate (figure 1A) and angular gyrus FDG-PET
ROIs (figure 1B) were such that a higher number of
years of education was associated with lower FDG-PET
metabolism in Ab1-42 (1) subjects, but a higher num-
ber of years of education was associated with higher
FDG-PET metabolism in Ab1-42 (2) subjects.
To ensure that subtle cognitive deficits in specific
cognitive domains, such as memory and executive
function, did not influence the findings, we repeated
the analyses of the interaction between CSF Ab1-42
status and education on FDG-PET, this time control-
ling for the composite measure of episodic memory or
executive function. The results on the interaction effect
remained virtually the same (tables e-1 and e-2).
In a secondary analysis, we conducted a selective
subgroup analysis on education, FDG-PET (posterior
cingulate ROI), and composite episodic memory in the
Ab1-42 (1) group in order to confirm the directionality
of the associations between the different variables in
the preclinical AD group. The results are presented in
appendix e-1.
Voxel-based mapping of interaction effect of education and
CSF Ab1-42 status on FDG-PET. Voxel-based mapping of
interaction effect of education and CSF Ab1-42 status on
FDG-PET is detailed in table e-3. Significant interac-
tion effects (education 3 CSF Ab1-42 status) were
observed within the bilateral temporal lobe, including
the hippocampus region and lateral temporal lobe struc-
tures, and the ventral prefrontal cortex (figure 2A). The











CSF Ab (2) 30 15.3 (3) 75.6 (5.5) 13/17 27/3b 28.8 (1.4) 0.8 (0.5) 0.6 (0.5)
CSF Ab (1) 22 16.3 (3.3) 74.9 (4.8) 6/16 10/12 29.3 (0.8) 0.9 (0.5) 0.5 (0.7)
Total 52 15.7 (3.2) 75.3 (5.2) 19/33 37/15 29.0 (1.2) 0.9 (0.5) 0.5 (0.6)
Abbreviations: Ab 5 amyloid-beta; HC 5 cognitively healthy; MMSE 5 Mini-Mental State Examination.
aValues are mean (SD).
bCSF Ab (2) vs Ab (2): p , 0.01 (2-sided t test).
1196 Neurology 80 March 26, 2013
ª"NFSJDBO"DBEFNZPG/FVSPMPHZ6OBVUIPSJ[FESFQSPEVDUJPOPGUIJTBSUJDMFJTQSPIJCJUFE
voxel-wise interaction effects were in the same direction
as observed in the ROI analysis reported above, i.e., for
the Ab1-42 (1) subject group, an increase in years of
education was associated with lower FDG-PET metab-
olism, whereas for the Ab1-42 (2) group, an increase in
years of education was associated with an increase in
FDG-PET metabolism. No significant interaction
effect in the opposite direction was observed. Mapping
of the spatial distribution of the effect sizes of the inter-
action effect showed that the largest effect sizes were
predominantly distributed within the medial temporal
lobe, inferior frontal lobe, and parietal lobe (figure 2B).
DISCUSSION FDG-PET hypometabolism within
temporo-parietal brain areas has been consistently
observed to develop early in the course of AD.18,19
The main finding of the current study including the
interaction effect of education 3 Ab1-42 status on
temporo-parietal FDG-PET showed that in preclini-
cal AD subjects (Ab1-42 [1]) but not normal elderly
subjects (Ab1-42 [2]) higher education was associated
with lower temporo-parietal FDG-PET metabolism
at a given level of cognitive performance. This finding
suggests that in the early stage of AD (abnormal Ab)
cognitive reserve (higher education) compensates
FDG-PET hypometabolism to maintain cognitive
performance.
Specifically, we interpret the findings as follows: at
higher levels of cognitive reserve, relatively low levels of
temporo-parietal FDG-PET metabolism (indicative of
more brain damage) can be tolerated to maintain nor-
mal cognition in preclinical AD. In contrast, at lower
levels of cognitive reserve, temporo-parietal FDG-
PET metabolism must be relatively high in preclinical
AD subjects (compared to the HC Ab1-42 [2]) in
order to maintain normal cognition. The increased
FDG-PET metabolism in preclinical AD with low
cognitive reserve can be explained by a selection effect:
subjects with low FDG-PET and low education are
more likely to show mild cognitive impairment
(MCI) or AD dementia than to stay cognitively nor-
mal.15 Results of our post hoc analysis in the preclinical
AD subjects showed that both higher posterior cingu-
late FDG-PET and higher education were associated
with higher memory performance, but higher educa-
tion was associated with lower posterior cingulate
FDG-PET, suggesting a compensatory role of educa-
tion with regard to FDG-PET hypometabolism to
maintain cognitive performance in preclinical AD.
Our findings on the association between higher
education and lower FDG-PET metabolism in sub-
jects with preclinical AD (CSF Ab1-42 [1]) are in
line with previous studies in patients with clinically
manifest AD dementia,3,5,20 which reported an asso-
ciation between higher education and lower FDG-
PET in the temporo-parietal brain areas while con-
trolling for global cognitive ability. Together the cur-
rent and previous results suggest that across different
clinical stages of AD, subjects with high cognitive
reserve can tolerate more FDG-PET hypometabolism
to maintain a certain level of cognitive performance
when compared to subjects with low cognitive
reserve.
A further implication of the current results is that
subjects with higher levels of cognitive reserve show
better cognitive performance at similar levels of brain
pathology. Such a notion is supported also by results
from previous studies showing a lower likelihood of
AD dementia or cognitive impairment in subjects
Table 2 Mean (SD) of FDG-PET ROIs in the HC subjects for each CSF Ab1-42
status
Group Sample size, n Posterior cingulate Angular gyrus
Inferior/middle
temporal gyrus
CSF Ab (2) 30 1.4 (0.2) 1.3 (0.2) 1.24 (0.1)
CSF Ab (1) 22 1.39 (0.2) 1.3 (0.2) 1.23 (0.2)
Abbreviations: Ab 5 amyloid-beta; HC 5 cognitively healthy; ROI 5 region of interest.




Posterior cingulate Angular gyrus Inferior/middle temporal gyrus (log)
B (SE) p B (SE) p B (SE) p
Intercept 2.56 (0.25) ,0.01 1.98 (0.31) ,0.01 0.55 (0.21) 0.01
Education 3 Ab status 20.03 (0.01) ,0.01 20.03 (0.01) 0.03 20.02 (0.01) 0.06
ADAS-cog 20.01 (0.004) 0.10 20.01 (0.01) 0.17 20.01 (0.004) 0.12
Age 20.02 (0.003) ,0.01 20.01 (0.004) 0.01 20.01 (0.01) 0.04
Education 0.02 (0.01) ,0.01 0.01 (0.01) 0.16 0.01 (0.01) 0.12
CSF Ab status 0.52 (0.16) ,0.01 0.41 (0.21) 0.05 0.25 (0.14) 0.08
Abbreviations: ADAS-cog 5 Alzheimer’s Disease Assessment Scale–cognitive subscale; ROI 5 region of interest.
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with higher cognitive reserve when controlling for
brain Ab measured by Pittsburgh compound B
(PiB) PET.21,22 Importantly, results from several stud-
ies suggest that cognitive reserve modifies the effect of
Ab on cognition (i.e., interaction between education
and Ab levels).21,23 In cognitively normal subjects, the
interaction between education and global brain PiB
PET was such that more education was associated
with better global cognitive ability at abnormally high
but not at normal levels of PiB PET21 (but see refer-
ence 24). These results suggest a compensatory role of
cognitive reserve (education) to maintain cognitive
performance in subjects with abnormal brain Ab lev-
els, and are in agreement with the current result of
increased tolerance of FDG-PET hypometabolism
associated with cognitive reserve (education) in pre-
clinical AD (HC Ab1-42 [1]).
Support for the hypothesis that cognitive reserve
compensates localized brain damage in AD comes
also from studies focusing on gray matter volume
changes. Greater brain atrophy and higher levels of
brain Ab have been reported in subjects with higher
cognitive reserve compared to subjects with lower
cognitive reserve in a pooled sample of cognitively
normal and cognitively impaired (MCI and AD
dementia) subjects.25 Together the previous and cur-
rent findings suggest that cognitive reserve is associ-
ated with relatively preserved cognitive performance
in the face of AD pathology (Ab) and AD-associated
functional (as assessed by FDG-PET) and structural
(as assessed by MRI) brain changes.
The current study includes caveats that should be
kept in mind when interpreting the results. First, we
have used education as a proxy of cognitive reserve,
but alternative measures including IQ, schooling, life
activities, and occupation have been previously used
to assess cognitive reserve.3–5,20,26,27 However, across
those studies using different measures of cognitive
reserve in AD dementia, an association between high-
er scores on cognitive reserve measures and lower
temporo-parietal FDG-PET was consistently re-
ported.3–5,20,26,27 Thus, it is unlikely that the current
results on the association between cognitive reserve
and temporo-parietal FDG-PET are specific to edu-
cation as a measure of cognitive reserve.
We note that in the current study a relatively
high proportion of HC subjects with abnormal Ab
(42%) was found. However, such a proportion is
still within the range of the proportion of elderly
HC subjects with abnormal CSF-Ab or PiB PET
levels reported previously (18–50%).28,29 Potential
factors that influence the size of the proportion of
subjects with abnormal brain Ab are age and APOE
genotype.28
It should be pointed out that the current study did
not address what neuronal mechanisms actively com-
pensate AD pathology and brain dysfunction (e.g.,
parietal FDG-PET hypometabolism). It has been
suggested that such compensatory mechanisms could
consist of the increased efficiency or capacity of task-
related networks (i.e., “neural reserve”), the ability to
recruit compensatory task-related networks (i.e.,
“neural compensation”), or generalized networks that
underlie cognitive support in the presence of
Figure 1 Scatterplot of the interaction between education and CSF Ab1-42
group for predicting FDG-PET
The number of years of education is plotted against FDG-PET for the regions of interest
(ROIs) of posterior cingulate gyrus (A) and angular gyrus (B). Regression lines are plotted
for groups including CSF Ab1-42 (2) indicated by black circles and CSF Ab1-42 (1) indicated
by red triangles.
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Figure 2 Voxel-wise assessment of the interaction effect education 3 CSF Ab1-42 status for predicting FDG-PET
The t statistics projected onto the surface (A) and the effect sizes projected onto axial slices (B) are displayed. In A, red shows those brain regions with
significant interaction effects (false discovery rate corrected at the cluster level at p 5 0.05). The interaction effects were all in the same direction as
reported for the region of interest (ROI) analysis, i.e., higher number of years of education was associated with lower FDG-PET in Ab1-42 (1) subjects, but the
reverse was true for Ab1-42 (2) subjects. There were no significant interaction effects in the opposite direction. In B, colors ranging between green/yellow
and red indicate the size of the interaction effects that were in the same direction as reported for the ROI analysis.
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pathology.1,30 Functional imaging studies have begun
to uncover cognitive reserve–related changes of brain
activity, including the prefrontal and temporal corti-
ces.30–35 In addition to functional network changes,
structural brain differences, such as bigger brain size
or white matter integrity, may allow for larger extent
of neuronal loss before cognitive deficits start to
emerge.36–38 However, it remains unclear how such
brain differences, which may be considered “brain
reserve,” relate to cognitive reserve and cognitive
function and remain to be described in future studies.
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